← All Pasithea Therapeutics CORP filings

Pasithea Therapeutics CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
KTTA
Pasithea Therapeutics CORP
10-K: Pasithea Therapeutics Reports 2024 Annual Results, Highlights Clinical Progress of PAS-004
Pasithea Therapeutics' 2024 annual report details financial results and provides updates on the clinical development of PAS-004 and other pipeline programs.
NASDAQ
KTTA
Pasithea Therapeutics CORP
10-K: Pasithea Therapeutics Corp. Files 2023 Annual Report, Highlights Clinical Progress and Strategic Focus
Pasithea Therapeutics Corp. released its 2023 annual report, detailing its shift to a therapeutics-focused company and progress in its clinical pipeline, particularly with PAS-004.